subscribe
A Rare Lysosomal Storage Disease
Contact: info@npcfund.org

Archive for May 2010

Orphan Drug Designation for Cyclodextrin | NPC

This week the FDA has stated formally that they see promise in the use of Cyclodextrin in treating Niemann-Pick Type C (NPC) by granting its “Orphan Drug Designation”. In January of 1983, the Orphan Drug Act (ODA) was passed into law in the United States with consistent […]

Read more

Why refer to it as the “Childhood Alzheimer’s”?

Why refer to it as the “Childhood Alzheimer’s”?

You possibly can recall someone you knew that suffered from Alzheimer’s disease. Currently 5.3 million Americans are living with this progressive and fatal brain disease with no cure (www.Alz.org). Alzheimer’s is progressively devastating in how it destroys brain cells, causes loss of memory (progressive dementia), and problems […]

Read more
Email Address First Name